Literature DB >> 3512328

Immunohistochemical characterization of plasma cells in Zoon's balanoposthitis and (pre)malignant skin lesions.

J Toonstra, D F van Wichen.   

Abstract

A retrospective study in 9 patients with Zoon's balanoposthitis was done to determine the immunoglobulin class distribution in the plasma cellular infiltrate. This was carried out on paraffin-embedded specimens using an unlabelled antibody peroxidase-antiperoxidase method. In all lesions IgG-producing plasma cells predominated. IgA- and IgD-positive cells were also present in about equal quantities but fewer than IgG. IgM-positive cells were either absent or present in very low numbers. Especially in erosive lesions a high number of plasma cells was noticed. The kappa/lambda ratio was variable with a preference for lambda in 5 of 8 cases. These findings are suggestive of a nonspecific polyclonal stimulation of B cells, which might be caused by a persistent infection. The above-mentioned findings were compared with premalignant and malignant skin lesions in which a major amount of plasma cells was present in the inflammatory infiltrate. Comparable results were obtained with slight variations. The role of plasma cells in these infiltrates is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3512328     DOI: 10.1159/000249302

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  3 in total

1.  Plasma cell balanitis: clinical and histopathological features--response to circumcision.

Authors:  B Kumar; R Sharma; M Rajagopalan; B D Radotra
Journal:  Genitourin Med       Date:  1995-02

2.  Vulvitis plasmacellularis: two new cases.

Authors:  I Neri; A Patrizi; S Marzaduri; R Marini; M Negosanti
Journal:  Genitourin Med       Date:  1995-10

Review 3.  Successful Management of Zoon's Balanitis with Topical Mupirocin Ointment: A Case Report and Literature Review of Mupirocin-Responsive Balanitis Circumscripta Plasmacelluaris.

Authors:  Omar Bari; Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2017-04-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.